251 related articles for article (PubMed ID: 36769264)
1. The Intracellular and Secreted Sides of Osteopontin and Their Putative Physiopathological Roles.
Bastos ACSDF; Gomes AVP; Silva GR; Emerenciano M; Ferreira LB; Gimba ERP
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769264
[TBL] [Abstract][Full Text] [Related]
2. Intracellular osteopontin (iOPN) and immunity.
Inoue M; Shinohara ML
Immunol Res; 2011 Apr; 49(1-3):160-72. PubMed ID: 21136203
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of intracellular and secreted osteopontin isoforms by murine macrophages in response to toll-like receptor agonists.
Zhao W; Wang L; Zhang L; Yuan C; Kuo PC; Gao C
J Biol Chem; 2010 Jul; 285(27):20452-61. PubMed ID: 20427276
[TBL] [Abstract][Full Text] [Related]
4. Osteopontin and their roles in hematological malignancies: Splice variants on the new avenues.
Bastos ACSF; Blunck CB; Emerenciano M; Gimba ERP
Cancer Lett; 2017 Nov; 408():138-143. PubMed ID: 28844708
[TBL] [Abstract][Full Text] [Related]
5. Osteopontin and the skin: multiple emerging roles in cutaneous biology and pathology.
Buback F; Renkl AC; Schulz G; Weiss JM
Exp Dermatol; 2009 Sep; 18(9):750-9. PubMed ID: 19558497
[TBL] [Abstract][Full Text] [Related]
6. Secreted-Osteopontin Contributes to Brown Adipogenesis In Vitro via a CD44-Dependent Pathway.
Wang M; Guo Y; Zhou Y; Yuan W; Li H; Xiong S; Wang K; Zeng G; Huang Q
Horm Metab Res; 2019 Nov; 51(11):741-748. PubMed ID: 31295749
[TBL] [Abstract][Full Text] [Related]
7. Osteopontin (OPN)/SPP1: from its biochemistry to biological functions in the innate immune system and the central nervous system (CNS).
Lin EY; Xi W; Aggarwal N; Shinohara ML
Int Immunol; 2023 Apr; 35(4):171-180. PubMed ID: 36525591
[TBL] [Abstract][Full Text] [Related]
8. Human osteopontin splicing isoforms: known roles, potential clinical applications and activated signaling pathways.
Gimba ER; Tilli TM
Cancer Lett; 2013 Apr; 331(1):11-7. PubMed ID: 23246372
[TBL] [Abstract][Full Text] [Related]
9. Both osteopontin-c and osteopontin-b splicing isoforms exert pro-tumorigenic roles in prostate cancer cells.
Tilli TM; Mello KD; Ferreira LB; Matos AR; Accioly MT; Faria PA; Bellahcène A; Castronovo V; Gimba ER
Prostate; 2012 Nov; 72(15):1688-99. PubMed ID: 22495819
[TBL] [Abstract][Full Text] [Related]
10. Osteopontin-4 and Osteopontin-5 splice variants are expressed in several tumor cell lines.
Silva GR; Mattos DS; Bastos ACF; Viana BPPB; Brum MCM; Ferreira LB; Gimba ERP
Mol Biol Rep; 2020 Oct; 47(10):8339-8345. PubMed ID: 33006711
[TBL] [Abstract][Full Text] [Related]
11. Osteopontin splice variants differentially exert clinicopathological features and biological functions in gastric cancer.
Tang X; Li J; Yu B; Su L; Yu Y; Yan M; Liu B; Zhu Z
Int J Biol Sci; 2013; 9(1):55-66. PubMed ID: 23289017
[TBL] [Abstract][Full Text] [Related]
12. Osteopontin-a splice variant is overexpressed in papillary thyroid carcinoma and modulates invasive behavior.
Ferreira LB; Tavares C; Pestana A; Pereira CL; Eloy C; Pinto MT; Castro P; Batista R; Rios E; Sobrinho-Simões M; Gimba ER; Soares P
Oncotarget; 2016 Aug; 7(32):52003-52016. PubMed ID: 27409830
[TBL] [Abstract][Full Text] [Related]
13. Secreted osteopontin from CD4
Aggarwal N; Deerhake ME; DiPalma D; Shahi SK; Gaggioli MR; Mangalam AK; Shinohara ML
Cell Rep; 2021 Dec; 37(13):110170. PubMed ID: 34965439
[TBL] [Abstract][Full Text] [Related]
14. Osteopontin: A Promising Therapeutic Target in Cardiac Fibrosis.
Abdelaziz Mohamed I; Gadeau AP; Hasan A; Abdulrahman N; Mraiche F
Cells; 2019 Dec; 8(12):. PubMed ID: 31816901
[TBL] [Abstract][Full Text] [Related]
15. Expression analysis of osteopontin mRNA splice variants in prostate cancer and benign prostatic hyperplasia.
Tilli TM; Thuler LC; Matos AR; Coutinho-Camillo CM; Soares FA; da Silva EA; Neves AF; Goulart LR; Gimba ER
Exp Mol Pathol; 2012 Feb; 92(1):13-9. PubMed ID: 21963599
[TBL] [Abstract][Full Text] [Related]
16. Two different isoforms of osteopontin modulate myelination and axonal integrity.
Nilsson G; Mottahedin A; Zelco A; Lauschke VM; Ek CJ; Song J; Ardalan M; Hua S; Zhang X; Mallard C; Hagberg H; Leavenworth JW; Wang X
FASEB Bioadv; 2023 Aug; 5(8):336-353. PubMed ID: 37554545
[TBL] [Abstract][Full Text] [Related]
17. Skewing of the population balance of lymphoid and myeloid cells by secreted and intracellular osteopontin.
Kanayama M; Xu S; Danzaki K; Gibson JR; Inoue M; Gregory SG; Shinohara ML
Nat Immunol; 2017 Sep; 18(9):973-984. PubMed ID: 28671690
[TBL] [Abstract][Full Text] [Related]
18. Osteopontin, intrinsic tissue regulator of intractable inflammatory diseases.
Uede T
Pathol Int; 2011 May; 61(5):265-80. PubMed ID: 21501293
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin-c splicing isoform contributes to ovarian cancer progression.
Tilli TM; Franco VF; Robbs BK; Wanderley JL; da Silva FR; de Mello KD; Viola JP; Weber GF; Gimba ER
Mol Cancer Res; 2011 Mar; 9(3):280-93. PubMed ID: 21263033
[TBL] [Abstract][Full Text] [Related]
20. Distinctive Prognostic Value and Cellular Functions of Osteopontin Splice Variants in Human Gastric Cancer.
Hao C; Cui Y; Lane J; Jia S; Ji J; Jiang WG
Cells; 2021 Jul; 10(7):. PubMed ID: 34359989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
